Vistide Related Published Studies
Well-designed clinical trials related to Vistide (Cidofovir)
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study. [2009.10]
Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study. [2008.07]
Well-designed clinical trials possibly related to Vistide (Cidofovir)
Cytomegalovirus. [2014]
First pharmacokinetic and safety study in humans of the novel lipid antiviral
conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA
viruses. [2012]
Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art. [2009.05]
Treatment results in adult-onset recurrent respiratory papillomatosis. [2009]
Antiviral agents for the treatment of recurrent respiratory papillomatosis: a systematic review of the English-language literature. [2007.06]
Other research related to Vistide (Cidofovir)
Activity, safety, and feasibility of cidofovir and imiquimod for treatment of
vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised,
phase 2 trial. [2014]
Novel treatment of atypical human papillomavirus-associated epithelial hyperplasia with cidofovir. [2011.09]
Intravenous cidofovir for resistant cutaneous warts in a patient with psoriasis treated with monoclonal antibodies. [2011.08]
Inhaled cidofovir as an adjuvant therapy for recurrent respiratory papillomatosis. [2011.04]
Novel method of intralesional cidofovir injection into laryngotracheal papillomata. [2011.04]
Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion. [2011.02]
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. [2011.01]
Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis. [2010.11]
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma. [2010.10.09]
Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. [2010.10]
Mitochondrial changes in cidofovir therapy for BK virus nephropathy. [2010.06]
Low-dose cidofovir in the treatment of symptomatic BK virus infection in patients undergoing allogeneic hematopoietic stem cell transplantation: a retrospective analysis of an algorithmic approach. [2010.05.07]
Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. [2010.05]
Mucosal bridge and pitting of the true vocal fold: an unusual complication of cidofovir injection. [2010.04]
Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis. [2010.04]
[The schedule of intralesional papillomatosis treatment with cidofovir] [2010.03]
Progressive multifocal leukoencephalopathy developed in incomplete Heerfordt syndrome, a rare manifestation of sarcoidosis, without steroid therapy responding to cidofovir. [2010.02]
Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin. [2010.02]
Effects of cidofovir on human papillomavirus-positive cervical cancer cells xenografts in nude mice. [2010]
Cidofovir does not prevent caprine herpesvirus type-1 neural latency in goats. [2010]
Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet. [2009.11]
Development of herpes simplex virus stomatitis during receipt of cidofovir therapy. [2009.10.15]
[Local application of cidofovir as adjuvant therapy in recurrent laryngeal papillomatosis in children] [2009.09]
In vitro analysis of cidofovir and genetically engineered TK expression as potential approaches for the intervention of ColoAd1-based treatment of cancer. [2009.09]
Safety and tolerability of cidofovir in high-risk pediatric patients. [2009.08]
Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study. [2009.07.15]
Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions. [2009.06]
Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections. [2009.06]
Adenovirus infection and treatment with cidofovir in children after liver transplantation. [2009.06]
Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin). [2009.06]
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. [2009.06]
Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment. [2009.05.01]
Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. [2009.05]
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature. [2009.04]
Squamous cell carcinoma associated with intralesional injection of cidofovir for recurrent respiratory papillomatosis. [2009.03]
The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. [2009.03]
Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited immune responses and immunity to monkeypox. [2009.01]
Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. [2009]
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease. [2009]
Assessing the efficacy of cidofovir against herpesvirus-induced genital lesions in goats using different therapeutic regimens. [2008.11]
Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation. [2008.11]
Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. [2008.11]
Topical cidofovir for severe warts in a patient affected by AIDS and Hodgkin's lymphoma. [2008.10]
Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir. [2008.10]
Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. [2008.09.12]
Cidofovir modulated gene expression in recurrent respiratory papillomatosis. [2008.09]
Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin). [2008.08.27]
Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis. [2008.08]
Follow-up of HPV DNA copy number in cidofovir therapy of recurrent respiratory papillomatosis. [2008.07]
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis. [2008.07]
Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model. [2008.05.20]
Adult intralesional cidofovir therapy for laryngeal papilloma: a 10-year perspective. [2008.05]
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir. [2008.05]
Successful treatment of florid cutaneous warts with intravenous cidofovir in an 11-year-old girl. [2008.05]
BK virus-associated nephropathy in a kidney transplant recipient successfully treated with cidofovir, the first case in Japan. [2008.04]
Differential pathogenesis of cowpox virus intranasal infections in mice induced by low and high inoculum volumes and effects of cidofovir treatment. [2008.04]
Cidofovir in combination with HAART and survival in AIDS-associated progressive multifocal leukoencephalopathy. [2008.04]
[Extensive oral condylomas treated by in situ cidofovir injection in an HIV patient] [2008.04]
Cidofovir injection for recurrent laryngeal papillomatosis. [2008.03]
High-risk adenovirus-infected pediatric allogeneic hematopoietic progenitor cell transplant recipients and preemptive cidofovir therapy. [2008.03]
Effect of topical ophthalmic application of cidofovir on experimentally induced primary ocular feline herpesvirus-1 infection in cats. [2008.02]
Cidofovir: to use or not to use? [2008.02]
Histologic review of cidofovir-treated recurrent respiratory papillomatosis. [2008.02]
Efficacy of therapeutic intervention with an oral ether-lipid analogue of cidofovir (CMX001) in a lethal mousepox model. [2008.01]
Low-dose cidofovir for the treatment of polyomavirus-associated nephropathy: two case reports and review of the literature. [2008]
Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients. [2007.09]
Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. [2007.09]
In vivo imaging of cidofovir treatment of cowpox virus infection. [2007.09]
Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis. [2007.08]
[Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir] [2007.07]
Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. [2007.06.15]
Dual infection with polyomavirus BK and acyclovir-resistant herpes simplex virus successfully treated with cidofovir in a bone marrow transplant recipient. [2007.06]
Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir. [2007.06]
Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. [2007.06]
[Intravesical cidofovir--instillation therapy for polyomavirus-associated hemorrhagic cystitis after bone marrow transplantation] [2007.05]
Cidofovir is effective against caprine herpesvirus 1 infection in goats. [2007.05]
[Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: efficacy of cidofovir] [2007.05]
Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. [2007.04.16]
Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. [2007.03]
Antiviral activity of HPMPC (cidofovir) against orf virus infected lambs. [2007.03]
Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. [2007.02]
Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. [2007.01]
Intralesional Cidofovir application in recurrent laryngeal papillomatosis. [2007.01]
Potent inhibition of genital herpesvirus infection in goats by cidofovir. [2007]
Chlorpromazine combined with cidofovir for treatment of a patient suffering from progressive multifocal leukoencephalopathy. [2007]
Mutations in the E9L polymerase gene of cidofovir-resistant vaccinia virus strain WR are associated with the drug resistance phenotype. [2006.12]
3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis. [2006.11]
Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection. [2006.11]
Encapsulation of antiviral nucleotide analogues azidothymidine-triphosphate and cidofovir in poly(iso-butylcyanoacrylate) nanocapsules. [2006.10.31]
Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy. [2006.10]
Cidofovir administered with radiation displays an antiangiogenic effect mediated by E6 inhibition and subsequent TP53-dependent VEGF repression in HPV18+ cell lines. [2006.10]
Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis. [2006.09]
Intravenous cidofovir-induced resolution of disfiguring cutaneous human papillomavirus infection. [2006.09]
Office-based intralesional cidofovir injections for nasal septal papilloma: a pilot study. [2006.07]
|